Robin Adelstein - Identified Individual
In the dynamic world of corporate law, Robin Adelstein stands out as a renowned figure in the field of antitrust and competition law. Based in New York and Washington D.C., Adelstein serves as the Global Head of Antitrust and Competition Law for a leading law practice [1].
Adelstein's extensive experience in litigation and counseling related to competition issues, merger control, regulatory investigations, and compliance enforcement is evident in her current role. While the specifics of her litigation cases remain confidential, her position as a global head underscores her extensive experience in this area.
Delving into Adelstein's past, her association with two major multinational corporations, Novartis and Diageo, provides a glimpse into her expertise. While the exact details of her roles within these companies are not publicly available, it is clear that she held positions of significant responsibility, likely involving legal or compliance strategies related to competition law.
At Novartis, Adelstein served as the North American General Counsel of Sandoz, the generics and biosimilars division of the company. This role undoubtedly provided her with a first-hand understanding of the importance of legal and compliance issues in a multibillion-dollar company.
In addition to her work in pharmaceuticals, Adelstein has extensive experience in the consumer products industry and other sectors. Her legal expertise extends to advising on various aspects of competition law, including antitrust issues associated with trade association activities, joint ventures, distribution practices, pricing programs, and competitor and customer communications.
Adelstein's expertise extends beyond traditional corporate boundaries. She has represented clients in matters related to healthcare, and she understands the importance of providing prompt, accurate, and practical advice on legal and compliance issues in this sector.
In the realm of government investigations, Adelstein has represented clients in investigations and litigation by numerous State Attorneys General. She also represents clients in government enforcement actions by the U.S. Federal Trade Commission and U.S. Department of Justice. Furthermore, she defends clients in qui tam matters in various locations.
Adelstein's background in balancing complex business objectives is evident in her ability to provide practical, effective solutions to her clients' legal challenges. Her experience in managing outside counsel, having redesigned and run the Novartis Preferred Firm Program globally, attests to her strategic acumen.
In summary, Robin Adelstein is a highly respected figure in the field of antitrust and competition law. Her expertise, gained through years of experience in various sectors and roles, makes her an invaluable asset to her clients and her current law practice.
[1] Information obtained from the law firm's website. For detailed information about her positions at Novartis and Diageo or her litigation cases, additional sources beyond the current search results would be required.
Robin Adelstein, in her current role as the Global Head of Antitrust and Competition Law, provides legal advice to clients in various sectors, demonstrating her expertise in competition law and business. With her extensive experience in litigation and counseling related to competition issues, she likely advises on aspects such as antitrust issues, joint ventures, distribution practices, pricing programs, and competitor and customer communications.
